Antibiotic Rotation for Febrile Neutropenic Patients with Hematological Malignancies: Clinical Significance of Antibiotic Heterogeneity

Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

(2011) Alison G. Freifeld et al.   CLINICAL INFECTIOUS DISEASES

Clinical impact of cycling the administration of antibiotics for febrile neutropenia in Japanese patients with hematological malignancy

(2011) S. Hashino et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies

(2011) Yong Chong et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Antibiotic heterogeneity: from concept to practice

(2010) A. M. Bal et al.   Annals of the New York Academy of Sciences

Rotation of antimicrobial therapy in the intensive care unit: impact on incidence of ventilator-associated pneumonia caused by antibiotic-resistant Gram-negative bacteria

(2010) E. Raineri et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Cefepime-resistant Gram-negative bacteremia in febrile neutropenic patients with hematological malignancies

(2010) Yong Chong et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Impact of a hospital-wide programme of heterogeneous antibiotic use on the development of antibiotic-resistant Gram-negative bacteria

(2010) Y. Takesue et al.   JOURNAL OF HOSPITAL INFECTION

Community‐Onset Bacteremia Due to Extended‐Spectrum β‐Lactamase–ProducingEscherichia coli:Risk Factors and Prognosis

(2009) Jesús Rodríguez‐Baño et al.   CLINICAL INFECTIOUS DISEASES

Bacteraemia due to extended-spectrum  -lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome

(2009) C. Gudiol et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Control of extended-spectrum  -lactamase-producing Klebsiella pneumoniae using a computer-assisted management program to restrict third-generation cephalosporin use

(2008) J. Y. Kim et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY